[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 112,550
Sort by:

Medicated Skin Care in Belarus

US$ 990.00

... . Rising urban population and stress levels in Belarus also resulted in an increase in the incidence of skin... Euromonitor International's Medicated Skin Care in Belarus report offers a comprehensive guide to the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 35 pages

Weight Management in Belarus

US$ 900.00

... to obesity products, which are only available in... Euromonitor International's Weight Management in Belarus report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the Weight Management market; Pinpoint growth sectors and identify factors driving ...

April 2012 23 pages

Medicated Skin Care in Turkey

US$ 990.00

... are usually cosmetic products rather than medicines. Euromonitor International's Medicated Skin Care in Turkey report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 28 pages

Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

US$ 3,700.00

... to Susan Eustis, lead author of the study, 'Reimbursement drives power wheelchair markets'. As people and governments pay for medical insurance more money ... , permitting the patient to control mobility for the rehabilitation efforts. Power wheel chairs give patients the ability to control movement. Transport ...

April 2012 467 pages

REGENERON: Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!

US$ 90.00

... with Bayer for Ex-US, wet AMD) launch skyrocketed Regeneron (REGN); we expect other TRAP based products in the pipeline to sustain this ... Sanofi granted A Priority Review for ZALTRAP (VEGF trap/ aflibercept, R, mCRC – 2nd-line; PhII/ ... 5, 2012 on REGN, titled “Tapping Other TRAPS in 3Q12 - ZALTRAP and ARCALYST!”

April 2012 5 pages

Medicated Skin Care in France

US$ 990.00

... drugs and Rx medicines because they are reimbursed. Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 42 pages

Medicated Skin Care in the US

US$ 990.00

... diapers, which increases the incidence of diaper rash. Euromonitor International's Medicated Skin Care in USA report offers a comprehensive guide to the size and shape ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

April 2012 53 pages

Healthcare Industry Deal Directory - Edition Q4'2011

US$ 350.00

The healthcare database provides access to all the Mergers and Acquisitions (M&A), Private Equity and Venture Capital Deals since 2004. The database is categorized into various sub-sectors includi...

April 2012

HARMONY 6 – Albiglutide Non-inferior on Efficacy to Humalog on top of Lantus, but competition better positioned to tap this market

US$ 90.00

GSK reported that topline data from Harmony 6 study met the primary end point. Albiglutide produced clinically significant reductions in HbA1c vs. ... Lantus after 26 wks of treatment. We do not see meaningful potential for albiglutide in the insulin population as the competition (IdegLira and Lyxumia-Lantus ...

April 2012 4 pages

Novartis, GSK - QVA149- Most Advanced once daily LABA+LAMA: Data positive but Competition follows closely

US$ 90.00

... ) exploring the efficacy and safety of QVA149. In the SHINE study (26 wk, n=2100), QVA149 showed statistically superior FEV1 reduction in comparison ... moderate to severe COPD patients. In a smaller BRIGHT study (3 wk), QVA149 demonstrated significant improvement in exercise endurance against placebo and in the ...

April 2012 2 pages

Healthcare Distribution and Services Industry in the US – PEST Framework Analysis

US$ 175.00

... , and other pharmaceuticals outlets. Aruvian's R'search analyzes the Healthcare Distribution and Services Industry in the United States in a PEST Framework Analysis. A PEST analysis is concerned with ...

April 2012 20 pages

Global Home Healthcare Device Industry 2012 - 2017: Trend, Profit, and Forecast Analysis

US$ 1,980.00

... the face of global home healthcare device industry. Lucintel’s study provides a concise overview of the global home healthcare device industry. The report tracks four regions of global home healthcare device industry. This study ... ) for global home healthcare device industry analysis Gross and net profit trends in the global home healthcare device industry analysis Cost structure trend in the global as well as regional home healthcare device industry ...

April 2012

UAE Healthcare Sector Forecast to 2014

US$ 1,200.00

In the past few years, the UAE healthcare industry has shown an unprecedented growth which is expected to continue in the future due to increasing population, rising prevalence of lifestyle diseases a...

March 2012 135 pages

Saudi Arabian Healthcare Forecast to 2015

US$ 1,000.00

Saudi Arabia represents the largest healthcare market in the GCC region that possesses a huge potential for further expansion due to rising healthcare needs. The government and health regulatory autho...

March 2012 115 pages

G-Protein Coupled Receptors (GPCRs): Market Research Report

US$ 4,500.00

This report analyzes the Global market for G-Protein Coupled Receptors (GPCRs) in US$ Billion. Annual estimates and forecasts are provided for ... through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 43 companies including 7TM Pharma A/S, Actelion Pharmaceuticals ...

March 2012 299 pages

Global RNAi Market Analysis

US$ 1,200.00

RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic app...

March 2012 105 pages

Herpes Simplex Virus Treatment: Market Research Report

US$ 4,600.00

This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Novartis International AG, Sanofi, Starpharma Holdings Limited, and Vical. Market data and analytics are derived from primary and secondary ...

March 2012 300 pages

Global Protein Therapeutics Market Forecast to 2015

US$ 1,800.00

Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat w...

March 2012 160 pages

Therapy Trends: Multiple Sclerosis

US$ 4,995.00

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse futu...

March 2012 160 pages

Market Access: Communicating Value Stories to Payers

US$ 595.00

... affiliate organisations. What strategies are emerging to tackle these challenges? Market Access: Communicating Value Stories to Payers shares up-to-the-minute insights and case studies from ... finding their way through this new environment. Report Overview Market Access: Communicating Value Stories to Payers provides unique, practical insights into how companies can ...

March 2012 46 pages

TOP TEN ANDA / PARA-IV / API OPPORTUNITIES TO BE TARGETED BY GENERIC OR ACTIVE PHARMACEUTICAL INGREDIENT COMPANIES

US$ 5,000.00

... of the 10 products screened, nine have not yet been targeted by Para-IV filer. The products selected span across four therapy areas ...

March 2012 60 pages

Roche - GSK - EMILIA: TDM1 ready to take over Tykerb

US$ 90.00

Today, Roche and ImmunoGen announced the topline data from EMILIA study ... T-DMI in this indication and this should come at the expense of GSK’s Tykerb, which is the current standard of care in this setting. This ...

March 2012 3 pages

Opportunities in the Telemedicine Market in India

US$ 1,000.00

Executive The telemedicine market in India has witnessed significant growth, owing to its potential of providing the world class clinical and medical services to distant and rural locations. The...

March 2012 30 pages

Merck - IMPROVE IT update - Appears trending favorably

US$ 90.00

Today, Merck announced that the Data Safety Monitoring Board has given a go-ahead signal to the IMPROVE-IT after it conducted a pre-specified second interim ... . The company has also indicated that the projected completion of IMPROVE IT by 2013 may change.

March 2012 1 pages

BMY, EINSTEIN PE: Needle-free single drug approach with no monitoring issue - Safer

US$ 90.00

At ACC, Bayer reported clinical data from EINSTEIN-PE study which compared the safety and effectiveness of Xarelto in the ... of anti-coagulant therapy for their acute episode of VTE (EINSTEIN-EXT Trial). In the EINSTEIN-EXT trial, after a mean treatment of 190 days ...

March 2012 2 pages

Medicated Skin Care in Argentina

US$ 990.00

... out of every 10 Argentine women in the country wear... Euromonitor International's Medicated Skin Care in Argentina report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

March 2012 30 pages

CHUGAI - Hefty Price Cut on Actemra Owing to Exceeding Projected Sales - Slightly Negative!

US$ 90.00

... is expected to be slightly negative. Apart from this, the overall impact of price cuts on Chugai is expected to be at par with industry i.e. ~6%. The reason for this ... NIH price of new drugs. Actemra has been very successful in RA since its launch in Japan in 2008 and remains a key growth driver for Chugai.

March 2012 3 pages

Medicated Skin Care in Estonia

US$ 990.00

Medicated skin care witnessed current value growth of 5% to reach EUR1.6 million in 2011 due to increased consumption. Consumers purchased medicated skin care products more freely in 2011 because ... decreased as well. Due to many positive factors, consumers’... Euromonitor International's Medicated Skin Care in Estonia report offers a comprehensive guide to the size and shape of the ...

March 2012 23 pages

Medicated Skin Care in Russia

US$ 990.00

... consultations with cosmetologists, trichologists and other professionals on... Euromonitor International's Medicated Skin Care in Russia report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

March 2012 43 pages

NATCO PHARMA- Entering the Big League through Multi Pronged Strategy

US$ 140.00

... ready to be filed for compulsory licenses. Natco has one of the most lucrative Para IV pipeline in India pharma currently with Para IVs on Copaxone ($2.8b in US), Revlimid ...

March 2012 10 pages

Fitness & Slimming Industry in India (2011-15)

US$ 500.00

EXECUTIVE SUMMARY Indian Fitness & Slimming Industry constitutes about 8% of the wellness market. Presently, the fitness industry is in its nascent stages. The industry is fairly fragmented...

March 2012 48 pages

The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living

US$ 3,995.00

... . These twin challenges are addressed in The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living The report ... the Marketplace Competitors and Competitive Analysis Sales estimates for each market segment represent U.S. revenues and are expressed in current dollars. Estimates ...

March 2012 185 pages

Medicated Skin Care in Lithuania

US$ 990.00

... little hesitation about spending on medicines recommended by a dermatologist. Euromonitor International's Medicated Skin Care in Lithuania report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...

March 2012 27 pages

Medicated Skin Care in Denmark

US$ 990.00

Medicated skin care grew by 1% in 2011 to reach sales of DKr144 million. The positive growth stemmed from consumers’ increasing willingness to self-medicate and cure their skin ... ) treatments and cold sore treatments are skin conditions that most sufferers... Euromonitor International's Medicated Skin Care in Denmark report offers a comprehensive guide to the size ...

March 2012 32 pages

Medicated Skin Care in New Zealand

US$ 990.00

... hundreds of regulations that are considered to hinder business practice in New Zealand. With regard to medicated skin care, this review was intended to reduce compliance costs for ... Regulations Act 1984 as ‘a product that is primarily a food,... Euromonitor International's Medicated Skin Care in New Zealand report offers a comprehensive guide to the size and shape of the ...

March 2012 36 pages

Medicated Skin Care in Bolivia

US$ 990.00

... from. This trend continued to drive demand for medicated skin care products in 2011. Euromonitor International's Medicated Skin Care in Bolivia report offers a comprehensive guide to the size and ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...

March 2012 30 pages

Medicated Skin Care in Bulgaria

US$ 990.00

... . Nizoral from Johnson & Johnson Bulgaria EOOD and Allergosan from Sopharma AD are the most popular brands in medicated skin care, and they retain their traditional popularity largely without significant marketing activities by their manufacturers. Euromonitor International's Medicated Skin Care in Bulgaria report offers ...

March 2012 24 pages

Regional Overview: Consumer Health Trends in Asia Pacific

US$ 2,000.00

... to gaining access to the largest region in the world. Euromonitor International’s Regional Overview: Consumer Health Trends in Asia Pacific global briefing examines the ... data. Why buy this report? Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors driving ...

March 2012 59 pages

Orthobiologics: Global Market Prospects 2012-2022

US$ 2,635.00

... -2022 also examines the size and value of leading national/regional markets. For each of these, visiongain identifies prevailing trends and strategies that ... of companies and leading products. Why you should buy Orthobiologics: Global Market Prospects 2012-2022 In this report, you will receive the following ...

March 2012 123 pages

Galapagos - Partnership Impact Sustainable?

US$ 140.00

Though deal with Abbott has added credibility to Galapagos’ GLPG0634 (PhII, an oral JAK1 inhibitor), there is still ... by 2014 could elevate GLPG, but our analysis of the impact of catalysts for 2012-13 suggest that …. GLPG0634 will be ... report released on 6th March on GLPG titled “Partnership Impact Sustainable?”

March 2012 6 pages

The US Nutritional and Dietary Supplements Market and Forecast to 2016: Edition 2012

US$ 595.00

The report on “The US Nutritional and Dietary Supplements Market and Forecast to 2016” provides extensive information on different types of health supplements demand trends and reasons for change. It...

March 2012 43 pages

GCC Healthcare Industry Overview

US$ 650.00

Description The GCC healthcare industry has witnessed a massive spurt in healthcare spend, expected to push the market to an estimated US$ 44 billion by 2015 and further to an estimated US$ 60 billio...

March 2012 61 pages

European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 Countries) 

US$ 11,495.00

In 2011, the European markets for bone graft substitute, dental membranes and tissue engineering products approached €248 million. Austria, Benelux ( ... -3i, Geistlich, Riemser (Curasan) and Non-Profit Tissue Banks lead the market, among many others. This report provides a comprehensive and detailed analysis ...

March 2012 249 pages

JAPAN DOMESTIC PHARMA- Competitive Landscape of Leading Therapy Classes - UPDATE

US$ 600.00

In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will ... breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.

March 2012 27 pages

ROCHE - CHUGAI, RoActemra monotherapy Superior to Humira: ADACTA Study

US$ 90.00

In a Ph IV ADACTA monotherapy study, RoActema has shown superior improvement ... the biologic RA market (~ $10B). The data should support Roche’s sNDA for 1st line approval in the US (submitted in December ... in EU where Actemra is already approved in first line, Roche will file for a label change based on this data.

March 2012 2 pages

Surgical Apparel Market in the United States

US$ 200.00

... even less than models of the past. The surgical apparel market in United States has plenty of competition but the field is narrowing ... analyzes the Surgical Apparel Market in the United States in a comprehensive report which covers the basics of the market including market profile, market statistics, analysis ...

March 2012 20 pages

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

US$ 2,600.00

This report “Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012” published in March 2012 provides a compilation ... market. The unique feature of weight reduction associated with the use GLP-1R agonists clearly differentiates this antidiabetic drug class from other ...

March 2012 231 pages

Global Surgical and Infection Control Device Industry 2012-2017: Trend, Profit, and Forecast Analysis, March 2012

US$ 1,980.00

... acquisition activity in global surgical & infection control device industry analysis Quarterly demand trend (Q1 2010-Q4 2011) and forecast analysis (Q1 2012 – Q4 2012) for global surgical & infection control device industry analysis Gross and net profit trends in the global surgical & infection control device analysis Cost structure trend in the global as well as regional surgical & infection control device ...

March 2012

Orthopedic Orthotics: Market Research Report

US$ 4,200.00

This report analyzes the worldwide markets for Orthopedic Orthotics in US$ Million by the following Product Segments: Orthopedic Braces (Knee Braces, Ankle Braces, & ... NV, Ossur hf., Restorative Care of America, Inc., and Zimmer Holdings, Inc. Market data and analytics are derived from primary and secondary ...

February 2012 291 pages

Orthopedic Prosthetics: Market Research Report

US$ 4,500.00

This report analyzes the worldwide markets for Orthopedic Prosthetics in US$ Million by the following Product Segments: Hip Prosthesis, Knee Prosthesis, and ... Aesculap Implant Systems, Inc., Biomet, Inc., Corin Group PLC, DePuy Orthopedics, Inc., MatOrtho™ Ltd., DJO Surgical, Exactech, Inc., Smith & Nephew Plc ...

February 2012 353 pages

Filters

Search

Categories

370
94
242
550
1,143
110,057
94

Publishers

179
1
100
32
25
102
94
2,211
109
23
40
8,299
68
562
988
34
29,954
248
501
3,036
1
1
2
3
1
16
257
537
361
106
1
1,357
2,180
60
1,696
8
8,921
1,697
4
3,714
983
19
1
321
4,852
2,748
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
270
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
33
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
350
1
4
6
1
3
9
1
3
5
1
1
1
90
2
3
4
1
77
15
980
1
3
1
17
227
128
16
4
412
3
74
2
6
5
10
1
3
118
33
336
196
47
474
7
45
1
22
13
138
2
4

Regions

58
48
35
31
30
29
29
26
26
23
22
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
36
57
41
54
60
101
26
30
55
3
34
2
2
1,179
115
172
26
33
94
14
49
53
28
18
62
25
23
39
23
43
24
14
51
28
38
132
48
65
67
204
52
17
56
42
31
48
47
37
36
19
62
150
34
31
30
17
17
16
14
136
57
49
30
15
457
1,819
71
1,614
921
765
184
2,008
99,858

Price

Date

Pages

Offers

93
23
905
1
2,735
269
1
1